Paid Clinical Trials in Daphne, AL
As of July 2026, 24 paid clinical trials are recruiting in Daphne, Alabama. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Daphne offers studies at sites including Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis for conditions such as Breast Cancer, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Breast Neoplasms. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Daphne
Filter results
0 clinical trials
·Clear filters·Top Research Study Locations in Daphne
Researchers run research studies in Daphne, AL at 8 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis | Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Locally Advanced Lung Non-Small Cell Carcinoma | 5 |
| Southern Cancer Center, PC | Breast Cancer, Carcinoma, Non-Small-Cell Lung, Breast Neoplasms | 5 |
| Southern Cancer Center | Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer, Limited Stage Small Cell Lung Cancer, Non-Small Cell Lung Cancer Metastatic | 4 |
| Alliance For Multispecialty Research - Daphne | Atherosclerotic Cardiovascular Disease, Cardiovascular Disease, Obesity | 2 |
| Southern Cancer Center Pc | Non-Small Cell Lung Cancer (NSCLC), Non-small Cell Lung Cancer (NSCLC) | 2 |
| Southern Cancer Center (SCC) | Breast Neoplasms, Lung Neoplasm Malignant | 2 |
| Alabama Orthopedic Sports Medicine & Baldwin County Surgery Center | Pain | 1 |
| Southern Cancer Center, P.C. | Non Small Cell Lung Cancer (Squamous or Non Squamous), Stage 4 NSCLC | 1 |
Active & Upcoming Studies in Daphne (2026)
Recruiting trials in Daphne grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (18 active studies)
- A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer. · Phase 2, Phase 3 · Eikon Therapeutics
- A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201) · Phase 3 · Bristol-Myers Squibb
Diabetes & metabolic (2 active studies)
- A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus · Phase 3 · AstraZeneca
- Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity · Phase 3 · Amgen
Neurology & pain (1 active study)
Common conditions studied in Daphne
- Breast Cancer (3 active studies)
- Recurrent Lung Non-Small Cell Carcinoma (3 active studies)
- Stage IV Lung Cancer AJCC v8 (3 active studies)
- Breast Neoplasms (2 active studies)
- Carcinoma, Non-Small-Cell Lung (2 active studies)
- Atherosclerotic Cardiovascular Disease (1 active study)
Leading research sponsors in Daphne
- SWOG Cancer Research Network
- Bristol-Myers Squibb
- Amgen
- AstraZeneca
- Merck Sharp & Dohme LLC
Frequently asked questions
How many paid clinical trials are currently recruiting in Daphne?
There are approximately 24 recruiting clinical trials in Daphne, Alabama listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Daphne pay participants?
Most recruiting trials in Daphne compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Daphne?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Daphne?
The most common conditions under active study in Daphne include Breast Cancer (3), Recurrent Lung Non-Small Cell Carcinoma (3), Stage IV Lung Cancer AJCC v8 (3), Breast Neoplasms (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Daphne?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Daphne on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Daphne?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Daphne?
Recruiting research sites in Daphne include Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis, Southern Cancer Center, PC, Southern Cancer Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Daphne right now?
The largest active categories in Daphne are Cancer & tumors (18), Diabetes & metabolic (2), Neurology & pain (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.